Subanalysis of Subjective Cognitive Measures From a Phase 2, Double-Blind, Randomized Trial of REL-1017 in Patients With Major Depressive Disorder.
The primary care companion for CNS disorders（2023）
摘要
ClinicalTrials.gov identifier: NCT03051256.
更多查看译文
关键词
cognitive measures,subjective,double-blind
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要